Our clients are biotech and pharma companies, NGOs, hospitals, governmental bodies, and international organisations.
We help companies demonstrate the contribution of their product to public health, determine its most critical characteristics, and set R&D priorities to maximise its impact.
We help public and semi-public bodies assess the impact of public health interventions, optimise these interventions, and anticipate epidemic threats.
Our experience includes malaria control, paediatric respiratory diseases, sexually transmissible infections, neglected tropical diseases, and nosocomial infections.
We pick and implement the most appropriate tools to solve your problem. These include statistical analysis, disease transmission models, intra-host models, and health economics.